Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-12-15

Clinical Trial Update: Rapid Detection of Group B Strep- 35-37 Week Study

View source ↗

Summary

The 35-37 week rapid detection trial for Group B streptococcal neonatal sepsis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Michigan | Conditions: Group B Streptococcus Neonatal Sepsis | Status: WITHDRAWN